Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation

The objective of this study was to compare infusion-related reactions and outcomes of using subcutaneous (subQ) alemtuzumab versus intravenous (i.v.) alemtuzumab as graft-versus-host disease (GVHD) prophylaxis for matched unrelated donor stem cell transplantations. Outcomes include incidence of cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Khilna, Parmar, Sapna, Shah, Shreya, Shore, Tsiporah, Gergis, Usama, Mayer, Sebastian, van Besien, Koen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carden Jennings Publishing 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128235/
https://www.ncbi.nlm.nih.gov/pubmed/26524732
http://dx.doi.org/10.1016/j.bbmt.2015.10.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128235/
https://www.ncbi.nlm.nih.gov/pubmed/26524732
http://dx.doi.org/10.1016/j.bbmt.2015.10.022

Ejemplares similares